内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Rani Therapeutics Holdings, Inc.

RANI · Nasdaq · CIK 0001856725 · Healthcare · Biotechnology

内部人信号

44.6 / 100

2 位买方 · 2 条买入交易行 · $50.0K 买入总额

为什么有这个信号？

买方广度较低
买入规模较低
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+14.0 / 35
买入规模+5.3 / 25
角色+13.0 / 20
近期性+2.3 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Imran TalatChief Executive Officer
○●○
Javadi AlirezaChief Technical Officer
○○
IMRAN MIR ADirector,TenPercentOwner
●
● 买入▼ 卖出○ 其他

—

买方广度与集中度

合资格买方2
买入集中度50%最大买方： Imran Talat · $25.2K
聚集买入 · 15天2 insiders峰值活动： 2026-07-17–2026-07-21

Roles in the peak window: Chief Executive Officer, Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

44.6 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 44.9
  2. 44.8
  3. 44.7
  4. 44.6
  5. 44.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

3买入
3卖出
7其他 Form 4 交易行
8SEC 申报 · 365天
买入2 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他4 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-2.8%
3M
+26.2%
6M
+8.0%
12M
+63.1%

波动率与流动性

波动率
210.8%
Beta
—
平均每日成交额
USD 582,307

估值

市值
—
P/E
—

基本面

利润率
—
ROE
-89.9%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
7,249,790
上期报告
7,116,584
日均成交量
624,094
回补天数
11.6

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-07-21IMRAN MIR A买入 (P)Class A Common Stock36,000USD 0.69USD 24,840SEC 申报 ↗
2026-07-17Imran Talat买入 (P)Class A Common Stock35,000USD 0.72USD 25,200SEC 申报 ↗
2025-10-23IMRAN MIR A买入 (P)Class A Common Stock2,083,334USD 0.61USD 1,270,834SEC 申报 ↗
2024-12-13McKinley Kate买入 (P)Class A Common Stock17,960USD 1.67USD 29,993SEC 申报 ↗
2024-12-09Imran Talat买入 (P)Class A Common Stock10,296USD 1.94USD 19,974SEC 申报 ↗
2023-12-06Imran Talat买入 (P)Class A Common Stock10,000USD 2.27USD 22,700SEC 申报 ↗
2023-12-04Imran Talat买入 (P)Class A Common Stock5,000USD 2.57USD 12,850SEC 申报 ↗
2023-11-29Imran Talat买入 (P)Class A Common Stock20,000USD 2.05USD 41,000SEC 申报 ↗
2023-11-24South Cone Investments Limited Partnership; South Lake One LLC买入 (P)Class A Common Stock5,265,165USD 2.01USD 10,582,982SEC 申报 ↗
2023-11-17BUTEL JEAN LUC买入 (P)Class A Common Stock50,500USD 2.03USD 102,515SEC 申报 ↗
2023-11-16Nanavaty Maulik买入 (P)Class A Common Stock500USD 1.98USD 990SEC 申报 ↗
2023-11-07Imran Talat买入 (P)Class A Common Stock5,000USD 2.00USD 9,975SEC 申报 ↗
2023-05-12South Cone Investments Limited Partnership; South Lake One LLC买入 (P)Class A Common Stock2,645USD 3.98USD 10,527SEC 申报 ↗
2023-05-11South Cone Investments Limited Partnership; South Lake One LLC买入 (P)Class A Common Stock2,610USD 3.87USD 10,101SEC 申报 ↗
2023-05-08South Cone Investments Limited Partnership; South Lake One LLC买入 (P)Class A Common Stock4,420USD 4.46USD 19,713SEC 申报 ↗

Form 4 申报证据

13 transaction lines in the latest 365-day window; 141 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-27Javadi Alireza代扣税 (F)Class A Common Stock309USD 0.76USD 235SEC 申报 ↗
2026-09-27Imran Talat代扣税 (F)Class A Common Stock7,928USD 0.76USD 6,025SEC 申报 ↗
2026-07-21IMRAN MIR A买入 (P)Class A Common Stock36,000USD 0.69USD 24,840SEC 申报 ↗
展开近期 Form 4 证据 (13 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-27Javadi Alireza代扣税 (F)Class A Common Stock309USD 0.76USD 235SEC 申报 ↗
2026-09-27Imran Talat代扣税 (F)Class A Common Stock7,928USD 0.76USD 6,025SEC 申报 ↗
2026-07-21IMRAN MIR A买入 (P)Class A Common Stock36,000USD 0.69USD 24,840SEC 申报 ↗
2026-07-17Imran Talat买入 (P)Class A Common Stock35,000USD 0.72USD 25,200SEC 申报 ↗
2026-06-27Javadi Alireza代扣税 (F)Class A Common Stock309USD 0.74USD 229SEC 申报 ↗
2026-06-27Imran Talat代扣税 (F)Class A Common Stock7,927USD 0.74USD 5,866SEC 申报 ↗
2026-03-27Javadi Alireza卖出 (S)Class A Common Stock386USD 0.78USD 301SEC 申报 ↗
2026-03-27Imran Talat代扣税 (F)Class A Common Stock9,099USD 0.81USD 7,370SEC 申报 ↗
2026-03-22Imran Talat代扣税 (F)Class A Common Stock8,916USD 1.13USD 10,075SEC 申报 ↗
2025-12-27Imran Talat代扣税 (F)Class A Common Stock7,906USD 1.40USD 11,068SEC 申报 ↗
2025-10-23IMRAN MIR A买入 (P)Class A Common Stock2,083,334USD 0.61USD 1,270,834SEC 申报 ↗
2025-10-21South Cone Investments Limited Partnership卖出 (S)Class A Common Stock4,000,000USD 2.77USD 11,080,000SEC 申报 ↗
2025-10-20South Cone Investments Limited Partnership卖出 (S)Class A Common Stock1,923,000USD 2.41USD 4,634,430SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码RANI
CIK0001856725
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史141 transaction lines from 2021-07-30 to 2026-09-27
87 P purchase lines · 11 S sale lines · 43 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.